121 related articles for article (PubMed ID: 22497730)
1. Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study.
Duerschmied D; Ahrens I; Mauler M; Brandt C; Weidner S; Bode C; Moser M
PLoS One; 2012; 7(2):e32656. PubMed ID: 22384279
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting.
Fifi JT; Brockington C; Narang J; Leesch W; Ewing SL; Bennet H; Berenstein A; Chong J
AJNR Am J Neuroradiol; 2013 Apr; 34(4):716-20. PubMed ID: 23194833
[TBL] [Abstract][Full Text] [Related]
3. The impact of sex on platelet responses to aspirin in patients with peripheral artery disease.
Suarez Ferreira SP; Hall RP; Morrow K; Patel S; Lee I; Hagos F; Zacharias N; Machlus K; Dua A
Am J Hematol; 2024 Apr; 99 Suppl 1(Suppl 1):S6-S12. PubMed ID: 38400527
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein signatures for high on-treatment platelet reactivity to aspirin and clopidogrel in peripheral artery disease.
Baidildinova G; Pallares Robles A; Ten Cate V; Kremers BMM; Heitmeier S; Ten Cate H; Mees BME; Spronk HMH; Wild PS; Ten Cate-Hoek AJ; Jurk K
Thromb Res; 2023 Oct; 230():105-118. PubMed ID: 37708596
[TBL] [Abstract][Full Text] [Related]
5. Response to clopidogrel in patients undergoing lower extremity revascularization.
Tawil M; Maldonado TS; Xia Y; Berland T; Cayne N; Jacobowitz G; Lugo J; Lamparello P; Sadek M; Rockman C; Berger JS
Vascular; 2023 Dec; 31(6):1110-1116. PubMed ID: 35590464
[TBL] [Abstract][Full Text] [Related]
6. Superoxide Dismutase and Clopidogrel: A Potential Role in Peripheral Arterial Disease Treatment.
Fakhri YA; Al-Ani AW
Dokl Biochem Biophys; 2024 Jun; 516(1):83-92. PubMed ID: 38700818
[TBL] [Abstract][Full Text] [Related]
7. Evaluating thrombosis risk and patient-specific treatment strategy using an atherothrombosis-on-chip model.
Akther F; Fallahi H; Zhang J; Nguyen NT; Ta HT
Lab Chip; 2024 May; 24(11):2927-2943. PubMed ID: 38591995
[TBL] [Abstract][Full Text] [Related]
8. Platelets: still a therapeutical target for haemostatic disorders.
Geraldo RB; Sathler PC; Lourenço AL; Saito MS; Cabral LM; Rampelotto PH; Castro HC
Int J Mol Sci; 2014 Oct; 15(10):17901-19. PubMed ID: 25295482
[TBL] [Abstract][Full Text] [Related]
9. Anti-platelet Therapy Resistance - Concept, Mechanisms and Platelet Function Tests in Intensive Care Facilities.
Mărginean A; Bănescu C; Scridon A; Dobreanu M
J Crit Care Med (Targu Mures); 2016 Jan; 2(1):6-15. PubMed ID: 29967831
[TBL] [Abstract][Full Text] [Related]
10. Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease.
Groh LA; Willems LH; Fintelman P; Reijnen MMPJ; El Messaoudi S; Warlé MC
Cardiol Ther; 2024 Mar; 13(1):233-242. PubMed ID: 38055176
[TBL] [Abstract][Full Text] [Related]
11. Modelling of the in-stent thrombus formation by dissipative particle dynamics.
Liu J; Fan Z; Ye X; Zhang Y; Liu M; Deng X
J Theor Biol; 2024 Apr; 582():111758. PubMed ID: 38336241
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of L-quebrachitol derivatives against platelet aggregation.
Cai PC; Liang XJ; Feng QX; Bao XF; Chen GL
J Asian Nat Prod Res; 2024 Mar; ():1-9. PubMed ID: 38509703
[TBL] [Abstract][Full Text] [Related]
13. Genetics of predicted platelet reactivity.
de Vries PS
Blood; 2023 Nov; 142(22):1851-1852. PubMed ID: 38032670
[No Abstract] [Full Text] [Related]
14. Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.
Spiliopoulos S; Pastromas G; Diamantopoulos A; Katsanos K
Expert Opin Pharmacother; 2014 Oct; 15(15):2205-17. PubMed ID: 25162471
[TBL] [Abstract][Full Text] [Related]
15. Review of aspirin and clopidogrel resistance in peripheral arterial disease.
Guirgis M; Thompson P; Jansen S
J Vasc Surg; 2017 Nov; 66(5):1576-1586. PubMed ID: 28893489
[TBL] [Abstract][Full Text] [Related]
16. High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease.
Bernlochner I; Jaitner J; Fries V; Dommasch M; Mayer K; Ott I; Langwieser N; Fusaro M; Laugwitz KL; Kastrati A; Ibrahim T
Vasa; 2016; 45(2):155-61. PubMed ID: 27058802
[TBL] [Abstract][Full Text] [Related]
17. The Novel Role of Noncoding RNAs in Modulating Platelet Function: Implications in Activation and Aggregation.
Cimmino G; Conte S; Palumbo D; Sperlongano S; Torella M; Della Corte A; Golino P
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108819
[TBL] [Abstract][Full Text] [Related]
18. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.
Diehl P; Olivier C; Halscheid C; Helbing T; Bode C; Moser M
Basic Res Cardiol; 2010 May; 105(3):379-87. PubMed ID: 19943165
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
